These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20532174)

  • 1. "Topological significance" analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response.
    Vellaichamy A; Dezso Z; JeBailey L; Chinnaiyan AM; Sreekumar A; Nesvizhskii AI; Omenn GS; Bugrim A
    PLoS One; 2010 Jun; 5(6):e10936. PubMed ID: 20532174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
    Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
    Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
    Bisoffi M; Klima I; Gresko E; Durfee PN; Hines WC; Griffith JK; Studer UE; Thalmann GN
    J Urol; 2004 Sep; 172(3):1145-50. PubMed ID: 15311059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen.
    Coutinho-Camillo CM; Salaorni S; Sarkis AS; Nagai MA
    Cancer Genet Cytogenet; 2006 Apr; 166(2):130-8. PubMed ID: 16631469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.
    Saraon P; Musrap N; Cretu D; Karagiannis GS; Batruch I; Smith C; Drabovich AP; Trudel D; van der Kwast T; Morrissey C; Jarvi KA; Diamandis EP
    J Biol Chem; 2012 Oct; 287(41):34019-31. PubMed ID: 22908226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.
    D'Antonio JM; Ma C; Monzon FA; Pflug BR
    Prostate; 2008 May; 68(7):698-714. PubMed ID: 18302219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
    Giménez-Bonafé P; Fedoruk MN; Whitmore TG; Akbari M; Ralph JL; Ettinger S; Gleave ME; Nelson CC
    Prostate; 2004 May; 59(3):337-49. PubMed ID: 15042610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems.
    Tasseff R; Nayak S; Salim S; Kaushik P; Rizvi N; Varner JD
    PLoS One; 2010 Jan; 5(1):e8864. PubMed ID: 20126616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
    Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells.
    Katta S; Srivastava A; Thangapazham RL; Rosner IL; Cullen J; Li H; Sharad S
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells.
    Tu LC; Yan X; Hood L; Lin B
    Mol Cell Proteomics; 2007 Apr; 6(4):575-88. PubMed ID: 17220478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular alterations associated with LNCaP cell progression to androgen independence.
    Shi XB; Ma AH; Tepper CG; Xia L; Gregg JP; Gandour-Edwards R; Mack PC; Kung HJ; deVere White RW
    Prostate; 2004 Aug; 60(3):257-71. PubMed ID: 15176055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independence of HIF1a and androgen signaling pathways in prostate cancer.
    Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
    BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
    Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
    Oosterhoff JK; Grootegoed JA; Blok LJ
    Endocr Relat Cancer; 2005 Mar; 12(1):135-48. PubMed ID: 15788645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells.
    Karan D; Kelly DL; Rizzino A; Lin MF; Batra SK
    Carcinogenesis; 2002 Jun; 23(6):967-75. PubMed ID: 12082018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
    Ettinger SL; Sobel R; Whitmore TG; Akbari M; Bradley DR; Gleave ME; Nelson CC
    Cancer Res; 2004 Mar; 64(6):2212-21. PubMed ID: 15026365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.